Northwestern Now company blog

New Covid nasal spray outperforms current antibody treatments in mice

A new protein-based antiviral nasal spray is being advanced to Phase I human clinical trials to treat COVID-19. It works by blocking the spike protein's ability to infect cells.
Points
181
HN comments
64
Submissions
1
Cited by
0 commenters

Science & Space2022

On Hacker News

SubmittedTitle on HNPointsComments
Apr 14, 2022New Covid nasal spray outperforms current antibody treatments in mice by geox18164

More from Northwestern Now

All 15 posts →

Related posts from the same era